ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "citrullination and rheumatoid arthritis (RA)"

  • Abstract Number: 16 • 2018 ACR/ARHP Annual Meeting

    Comprehensive Antibody Profiling Using High Density Peptide Arrays Reveals Novel Citrullinated Protein Targets in Rheumatoid Arthritis Serum Samples

    Ken Lo1, Hanying Li2, Eric Sullivan2 and Jigar Patel2, 1Technology Innovation, Roche Sequencing Solutions - Madison, Madison, WI, 2Roche Sequencing Solutions - Madison, Madison, WI

    Background/Purpose: Autoantibodies against citrullinated proteins are found in 64-89% of rheumatoid arthritis (RA) patients, with a specificity of 88-99%. While citrullinated vimentin, fibrin and histone…
  • Abstract Number: 1471 • 2018 ACR/ARHP Annual Meeting

    ECV304 Cells Self-Citrullinate Proteins Targeted By Anti-Citrullinated Protein/Peptide Autoantibodies from Rheumatoid Arthritis Patients

    Natalia Regine de Franca Shimabukuro1,2, Maximilien Lora1, Mariana Useche3, Zhijie Zhou4, Joyce Rauch5, Luis Eduardo Coelho Andrade2, Henri Menard1 and Ines Colmegna6, 1The Research Institute of the McGill University Health Centre, Montreal, QC, Canada, 2Federal University of São Paulo, São Paulo, Brazil, 3Medicine, The Research Institute of the McGill University Health Centre, Montreal, QC, Canada, 4Aurora Medical Centre, Oshkosh, WI, 5Division of Rheumatology, The Research Institute of the McGill University Health Centre, Montreal, QC, Canada, 6The Research Institute of the McGill University Health Centre, Division of Rheumatology, Department of Medicine, McGill University, Montreal, Quebec, Canada, Montreal, QC, Canada

    Background/Purpose: Anti-citrullinated protein/peptide autoantibodies (ACPAs) define a major subset of rheumatoid arthritis (RA) patients. Cyclic citrullinated peptides (CCP) are commonly used as the antigen for…
  • Abstract Number: 2056 • 2018 ACR/ARHP Annual Meeting

    Citrullination Is Not a Determinant in the Lack of Tolerance to Peptidylarginine Deiminase 2 and 4 in Rheumatoid Arthritis

    Pooja Naik1, Ryan Davis2, Jon T. Giles3, Felipe Andrade4 and Erika Darrah5, 1Department of Medicine, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 2Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 3Columbia University, New York, NY, 4Medicine/Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 5Department of Medicine/Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD

    Background/Purpose: Peptidylarginine deiminase (PAD) 2 and 4 are targets of the humoral response in RA. However, the mechanisms by which these enzymes become immunogenic in…
  • Abstract Number: 492 • 2017 ACR/ARHP Annual Meeting

    Is Leukotoxin_A Produced By Aggregatibacter Actynomycetemcomitans Important for Initiating Autoimmune Responses Underlying Rheumatoid Arthritis?

    Mikhail Volkov1, Jacqueline Dekkers1, Bruno G. Loos2, Sergio Bizzarro2, Tom W.J. Huizinga3, Helle A. Praetorius4, Rene E.M. Toes5 and Diane van der Woude1, 1Department of Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Department of Periodontology, Academic Centre for Dentistry Amsterdam, University of Amsterdam and Vrije Universiteit, Amsterdam, Netherlands, 3Department of Rheumatology, LUMC, Leiden, Netherlands, Leiden, Netherlands, 4Department of Biomedicine, Aarhus University, Aarhus, Denmark, 5Rheumatology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: In a recent publication in Science Translational Medicine, Konig et al. (2016) describe a potential explanation for the link between periodontal infection and RA.…
  • Abstract Number: 1072 • 2017 ACR/ARHP Annual Meeting

    Mutated Peptidylarginine Deiminase from Porphyromonas Gingivalis Is a Target in Rheumatoid Arthritis and Citrullinates Major RA-Autoantigens

    Madeleine Jenning1, Bianka Marklein1, Jimmy Ytterberg2, Gerd R. Burmester1 and Karl Skriner1, 1Department of Rheumatology and Clinical Immunology, Charité - University Medicine Berlin, Free University and Humboldt University Berlin, Berlin, Germany, 2Dept. of Medicine, Rheumatology Unit, Karolinska Institutet, Karolinska University Hospital, Stockholm, Sweden

    Background/Purpose: Previous reports showed that peptidylarginine deiminase (PPAD) form Porphyromonas gingivalis (P.g.) is not able to citrullinate proteins internally. Mutated PPAD (mPPAD) from P.g. involved…
  • Abstract Number: 527 • 2015 ACR/ARHP Annual Meeting

    Characterisation of the Antibody Response to a Citrullinated Peptide – Derived from the Porphyromonas Gingivalis Peptidyl Arginine Deiminase Enzyme – in Patients with Rheumatoid Arthritis

    Nastya Kharlamova1, Xia Jiang2, Natalia Sherina3, Monika Hansson4, K. Lundberg5 and Lars Alfredsson6, 1Rheumatology Unit, Department of Medicine, Solna, Karolinska Institute, Stockholm, Sweden, 2Rheumatology, karolinska institutet, skärholmen, Sweden, 3Rheumatology, karolinska institutet, Stockholm, Sweden, 4Rheumatology Unit, Department of Medicine, Karolinska Institutet, Stockholm, Sweden, 5Karolinska Institute, Stockholm, Sweden, 6The Institute of Environmental Medicine, Karolinska Institutet, Stockholm, Sweden

    Background/Purpose: It has been hypothesized that Porphyromonas gingivalis - the only known pathogen to express a citrullinating enzyme (called P.PAD) - is etiologically linked to…
  • Abstract Number: 965 • 2015 ACR/ARHP Annual Meeting

    Crystal Structure of Porphyromonas Gingivalis peptidylarginine Deiminase: Implications for Autoimmunity in Rheumatoid Arthritis

    Anna B. Montgomery1, Jolanta Kopec2, Leela Shresha2, Marie-Laetitia Thezenasc3, Nicola A. Burgess-Brown2, Roman Fischer3, Wyatt W. Yue2 and Patrick J. Venables1, 1Kennedy Institute of Rheumatology, University of Oxford, Oxford, United Kingdom, 2Structural Genomics Consortium, University of Oxford, Oxford, United Kingdom, 3Target Discovery Institute, University of Oxford, Oxford, United Kingdom

    Background/Purpose: Anti-citrullinated protein antibodies (ACPA) are the main autoantibody system in rheumatoid arthritis (RA), and due to high sensitivity and specificity testing using the anti-CCP2…
  • Abstract Number: 2917 • 2014 ACR/ARHP Annual Meeting

    Inhibition of PAD4 Activity and the Formation of Neutrophil Extracellular Traps Via PTPN22, but Not Its Rheumatoid Arthritis-Prone W620 Variant

    I-Cheng Ho1, Hui-Hsin Chang1, Nishant Dwivedi1, Hsiao-Wei Tsao1 and Anthony Nicholas2, 1Medicine, Brigham and Women's Hospital, Boston, MA, 2Neurology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: One unique feature of rheumatoid arthritis (RA) is the presence of anti-citrullinated protein antibody (ACPA). Protein citrullination, a process mediated by peptidyl arginine deiminases,…
  • Abstract Number: 1426 • 2014 ACR/ARHP Annual Meeting

    Periodontal disease and Clinical Activity of Rheumatoid Arthritis Patients

    Daniel Xibille-Friedmann1, Jose Ivan Martinez Rivera2, Jaqueline Rodriguez Amado3, Carolina Bustos Rivera Bahena4, Marisol Sandoval Rios5 and Jose Luis Montiel Hernandez6, 1Rheumatology, Hospital General de Cuernavaca, Cuernavaca, Mexico, 2Instituto Nacional de Salud Publica, Cuernavaca, Mexico, 3Universidad Autónoma de Nuevo Leon, Centro de Investigación y Desarrollo en Ciencias de la Salud, Monterrey, Mexico, 4Universidad Autonoma del Estado de Morelos, Science Faculty, Cuernavaca, Mexico, 5Universidad Autonoma del Estado de Morelos, Faculty of Pharmacy, Cuernavaca, Mexico, 6Cytokines and Autoimmunity Laboratory, Faculty of Pharmacy, Universidad Autónoma del Estado de Morelos, Cuernavaca, México, Cuernavaca, Mexico

    Background/Purpose: Although several studies have suggested the association between periodontitis, infection by Porphyromona gingivalisand Rheumatoid Arthritis disease activity, its relationship with periodontal disease, oral and…
  • Abstract Number: 2819 • 2013 ACR/ARHP Annual Meeting

    Administration Of a Multi-Epitope Citrullinated Peptide Attuneuates adjuvant  Induced Arthritis In Rats Via Induction Of Immune Tolerance

    Howard Amital1, Smadar Gertel2 and Yehuda Shoenfeld3, 1The Zabludowicz Center For Autoimmune Diseases, and Department of Medicine 'B',, Sheba Medical Center,Tel-Hashomer, Tel-Aviv University, Tel-hashomer, Israel, 2The Zabludowicz Center For Autoimmune Diseases, and Department of Medicine 'B', Sheba Medical Center, Tel-Hashomer, Israel, 3Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Affiliated to Sackler Faculty of Medicine, Tel-Aviv University,Tel-Aviv, Tel-Aviv, Israel

    Background/Purpose: Antigen-induced peripheral tolerance is a potentially efficient and specific therapeutic approach to attenuate autoimmunity. Citrullinated peptides are major targets of disease-specific autoantibodies in Rheumatoid…
  • Abstract Number: 2685 • 2013 ACR/ARHP Annual Meeting

    Anti-Peptidylarginine Deiminase 3/4 Cross-Reactive Antibodies Are Associated With Radiographic Interstitial Lung Disease In Rheumatoid Arthritis, An Effect Potentiated By Smoking

    Jon T. Giles1, Erika Darrah2, Sonye K. Danoff3, Cheilonda Johnson4, Felipe Andrade5, Antony Rosen2 and Joan M. Bathon6, 1Division of Rheumatology, Columbia University, College of Physicians & Surgeons, New York, NY, 2Division of Rheumatology, Johns Hopkins University, Baltimore, MD, 3Medicine/Pulmonary, Johns Hopkins University, Baltimore, MD, 4Medicine/Pulmonology, Johns Hopkins University, Baltimore, MD, 5Division of Rheumatology, Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, MD, 6Columbia University, New York, NY

    Background/Purpose: Antibodies targeting citrullinated proteins (ACPA) are implicated in the pathogenesis of interstitial lung disease (ILD) in rheumatoid arthritis (RA).  Citrullinated proteins and the enzymes…
  • Abstract Number: 1890 • 2013 ACR/ARHP Annual Meeting

    Chemokine Receptor Polymorphisms On Chromosome 3 Are Associated With Anticitrullinated Protein Antibody Specificities In African Americans With Rheumatoid Arthritis

    Richard J. Reynolds1, Maria I. Danila2, Jeremy Sokolove3, William H. Robinson4, Doyt L. Conn5, Beth L. Jonas6, Leigh F. Callahan7, Larry W. Moreland8, Richard D. Brasington9, Edwin A. Smith10, Peter K. Gregersen11 and S. Louis Bridges Jr.12, 1Clinical Immunology and Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 2Med/Clinical Immun & Rheum, Univ of Alabama-Birmingham, Birmingham, AL, 3VA Palo Alto Healthcare System and Stanford University, Palo Alto, CA, 4Division of Immunology and Rheumatology, Stanford University School of Medicine, Stanford, CA, 5Rheumatology, Emory Univ School of Medicine, Atlanta, GA, 6Thurston Arthritis Research Ct, University of North Carolina at Chapel Hill, Chapel Hill, NC, 7Thurston Arthritis Res Ctr, University of North Carolina, Chapel Hill, NC, 8Division of Rheumatology and Clinical Immunology, University of Pittsburgh, Pittsburgh, PA, 9Div of Rheumatology, Washington Univ School of Med, St. Louis, MO, 10Dept of Med Div of Rheum, Med Univ of South Carolina, Charleston, SC, 11Genomics and Human Genetics, Feinstein Institute for Medical Research, Manhasset, NY, 12Division of Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: ACPA antibody specificities to citrullinated autoantigens (e.g., histones, vimentin, fibrinogen) are associated with the preclinical phase of RA and may predict the onset of…
  • Abstract Number: 913 • 2013 ACR/ARHP Annual Meeting

    High Throughput Epitope Mapping Of Autoantibodies In BXD2 Mice Reveals The Generation Of Autoantibodies Against Citrullinated Antigens At The Predicted Major Immunogenic Sites

    Jennie Hamilton1, Qi Wu2, PingAr Yang2, Hui-Chen Hsu3 and John D. Mountz4, 1University of Alabama at Birmingham, Birmingham, AL, 2Division of Clinical Immunology and Rheumatology, Department of Medicine, University of Alabama at Birmingham, Birmingham, AL, 3Department of Medicine, Clinical Immunology & Rheumatology, University of Alabama at Birmingham, Birmingham, AL, 4Dept of Med/Rheumatology Div, University of Alabama at Birmingham, Birmingham, AL

    Background/Purpose: Increased polyreactive B cells have been identified in patients with systemic lupus erythematous (SLE) and rheumatoid arthritis (RA).  Such autoantibodies (autoAbs) were also identified…
  • Abstract Number: 423 • 2013 ACR/ARHP Annual Meeting

    Serological Biomarkers For The Development Of Rheumatoid Arthritis Related Interstitial Lung Disease

    Elena Nikiphorou1, Esther Chan2, Vadivelu Saravanan2, Julie Dawson3, Navtej Sathi4, Felix Woodhead5, Mohamed Nisar6, Subhashini Arthanari6, Yasmeen Ahmad7, Adam Young8 and Clive Kelly2, 1Research Department of Epidemiology & Public Health, UCL and Rheumatology Department, St Albans City Hospital, ERAS, St Albans City Hospital & University College London (UCL), London, United Kingdom, 2Rheumatology, Queen Elizabeth Hospital, Gateshead, United Kingdom, 3Rheumatology, St Helens Hospital, St Helens, United Kingdom, 4Rheumatology, Wrightington Hospital, Wigan, United Kingdom, 5Respiratory, University Hospitals Coventry and Warwickshire, Coventry, United Kingdom, 6Rheumatology, Burton Hospital, Burton-on-Trent, United Kingdom, 7Department of Rheumatology, Peter Maddison Research Centre, Bangor, United Kingdom, 8Rheumatology, ERAS, St Albans City Hospital, St Albans, United Kingdom

    Background/Purpose: Interstitial Lung Disease (ILD) is the commonest manifestation of lung disease in Rheumatoid Arthritis (RA) and the only complication reported to be increasing in…
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology